We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Randox Laboratories

Provides global diagnostic solutions for hospital laboratories, forensic laboratories, research laboratories, pharmac... read more Featured Products: More products

Download Mobile App




CO-Oximetry External QA Programme Launched

By LabMedica International staff writers
Posted on 22 Mar 2018
Co-oximetry is a methodology that measures the levels of the oxygen-carrying protein haemoglobin, which is the chief component of red blood cells and CO-oximetry is useful in defining the causes for hypoxemia, or hypoxia.

Co-oximetry is a useful tool in that it helps determine the levels of various forms of haemoglobin and can be used to diagnose a variety of conditions related to oxygen content in blood. More...
Oxygen content is an important indicator of oxygen transport within the body. The oxygen transport of arterial blood is used to evaluate the ability of transporting oxygen from the lungs to the tissue.

A new CO-Oximetry programme to complement their existing Blood Gas programme has been launched by Randox (Crumlin, UK). The programme combines seven parameters in a user-friendly, liquid ready-to-use format, the new RIQAS CO-Oximetry External Quality Assessment (EQA) programme has been designed with consolidation and convenience in mind and it is even suitable for use in point-of-care testing. All samples are supplied in a liquid ready-to-use format ideal for both clinical and point-of-care testing.

The seven parameters covered by the programme are: Carboxyhaemoglobin (COHb / HbCO); Methaemoglobin (MetHb); Oxygen Content (O₂CT); Oxygen Saturation (sO₂ / Vol O₂); Oxyhaemoglobin (O₂Hb / HbO₂); Total Haemoglobin (tHb); and Reduced / Deoxyhaemoglobin (RHb / HHb). A high value for the Co-Oximetry Blood Test may indicate, among other things: carbon monoxide poisoning or congenital haemoglobin disorder. To compliment the RIQAS CO-Oximetry EQA Programme, the RIQAS Blood Gas EQA programme incorporates 10 parameters into a liquid ready-to-use format for ease of use.

RIQAS is the world’s largest EQA scheme with 45,000 participants and 33 programmes ensuring peer groups are maximised. Lynsey Adams, BSc, the Quality Control Marketing Manager at Randox, said, “The launch of our new CO-Oximetry programme means we now offer a complete EQA solution for blood gas testing.”


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Staining Management Software
DakoLink
New
Automated PCR Setup
ESTREAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.